This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Robert J. Sherertz, MD
Bowman Gray School of Medicine

Stephen A. Streed, MS
North Carolina Baptist Hospital Winston-Salem, NC

JAMA. 1995;273(24):1906-1907.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We are pleased that Ms Segal's IRB is knowledgeable about the issues discussed in our article. The fact that it was inconceivable to her that our problem developed is irrelevant. The reason the article was written was that it did happen to us and that a survey of other similar institutions demonstrated to us that it could happen to others as well. Perhaps the process by which IRBs become aware of relevant FDA regulations needs to be more standardized so that such disparities in knowledge between IRBs will not occur.

Dr Huffaker feels that the FDA makes it too difficult for manufacturers to modify medical devices and his implication is that we agree with them. We did not actually address the level of FDA regulation that should exist to oversee the modification of medical devices. We focused on the lack of understanding of the medical community related to . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?